V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159184 | 20061079 | 1.61 | 97.7 | Curative (C) | 2018-04-28 | 2018-05-12 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100065057 |
| 20159185 | 20061080 | 1.69 | 70.4 | Adjuvant (A) | 2017-11-01 | 2017-11-04 | ECX | N | N | ECX | 100341455 |
| 20159188 | 20061081 | 1.66 | 121.4 | Curative (C) | 2016-08-18 | 2016-09-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101207440 |
| 20159189 | 20061082 | 1.62 | 68.9 | Neo-adjuvant (N) | 2019-03-20 | 2019-04-01 | ECX | null | N | ECX | 101870991 |
| 20159191 | 20061083 | 1.63 | 66.9 | Disease modification (D) | 2017-05-28 | 2017-06-12 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101166803 |
| 20159195 | 20061084 | 1.67 | 81.4 | Neo-adjuvant (N) | 2018-12-12 | 2019-01-02 | ECX | N | N | ECX | 100303061 |
| 20159196 | 20061085 | 1.74 | 96 | Adjuvant (A) | 2020-01-08 | 2020-01-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101053708 |
| 20159197 | 20061086 | 1.86 | 93 | Neo-adjuvant (N) | 2019-05-08 | 2019-06-17 | ECX | 02 | N | ECX | 100396071 |
| 20159198 | 20061087 | 1.78 | 73.8 | Palliative (P) | 2019-09-03 | 2019-09-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100599689 |
| 20159199 | 20061088 | 1.55 | 73 | Adjuvant (A) | 2018-09-28 | 2018-10-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101327572 |
| 20159201 | 20061089 | 1.69 | 49.1 | Adjuvant (A) | 2020-01-22 | 2020-02-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101154181 |
| 20159202 | 20061090 | null | null | Palliative (P) | 2019-11-10 | 2019-12-13 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100225863 |
| 20159203 | 20061091 | 1.69 | 61.9 | Curative (C) | 2018-09-24 | 2018-09-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100223406 |
| 20159204 | 20061092 | 1.63 | 69 | Curative (C) | 2019-10-13 | 2019-11-08 | ECX | N | N | ECX | 100649301 |
| 20159208 | 20061093 | 1.6 | 46 | Palliative (P) | 2018-01-04 | 2018-01-23 | ECX | N | N | ECX | 101193651 |
| 20159209 | 20061094 | 1.61 | 56.3 | Adjuvant (A) | 2016-12-22 | 2017-01-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101297985 |
| 20159210 | 20061095 | null | 80.3 | Adjuvant (A) | 2018-04-08 | 2018-04-11 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101694665 |
| 20159213 | 20061096 | 1.8 | 88 | null | 2017-06-19 | 2017-07-25 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 100588204 |
| 20159216 | 20061097 | 1.81 | 76.9 | Curative (C) | 2018-07-06 | 2018-07-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100568829 |
| 20159220 | 20061098 | 1.68 | 90.4 | Palliative (P) | 2017-12-27 | 2017-12-27 | ECX | N | N | ECX | 101678783 |
| 20159222 | 20061099 | 1.7 | 83.1 | Neo-adjuvant (N) | 2018-05-04 | 2018-05-18 | ECX | N | N | ECX | 100886800 |
| 20159224 | 20061100 | 1.56 | 60 | Palliative (P) | 2018-06-07 | 2018-06-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101330006 |
| 20159225 | 20061101 | 1.76 | 95.5 | Curative (C) | 2017-09-27 | 2017-09-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100017230 |
| 20159226 | 20061102 | 1.88 | 53.3 | Palliative (P) | 2019-05-04 | 2019-05-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100342945 |
| 20159227 | 20061103 | 1.6 | 79.3 | Adjuvant (A) | 2018-01-01 | 2018-01-14 | CAPECITABINE + GEMCITABINE | 2 | Y | CAPECITABINE + GEMCITABINE | 100948785 |
| 20159228 | 20061104 | 1.77 | 65.5 | Neo-adjuvant (N) | 2016-12-14 | 2016-12-20 | ECX | 2 | N | ECX | 101747284 |
| 20159229 | 20061105 | 1.61 | 56.3 | Palliative (P) | 2017-01-11 | 2017-01-12 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100623789 |
| 20159231 | 20061106 | 1.75 | 97.8 | Palliative (P) | 2016-06-02 | 2016-06-23 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 100025691 |
| 20159232 | 20061107 | 1.64 | 101.8 | null | 2017-07-22 | 2017-07-25 | ECX | 02 | N | ECX | 100618807 |
| 20159233 | 20061108 | 1.72 | 55.8 | null | 2016-03-24 | 2016-04-08 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101579879 |
| 20159238 | 20061109 | 1.8 | 103 | Palliative (P) | 2017-11-16 | 2017-11-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101564818 |
| 20159239 | 20061110 | 1.61 | 77.4 | Palliative (P) | 2018-12-13 | 2018-12-26 | ECX | N | N | ECX | 101381593 |
| 20159240 | 20061111 | 1.68 | 51.6 | Palliative (P) | 2002-03-15 | 2016-02-07 | ECX | N | N | ECX | 101608329 |
| 20159241 | 20061112 | 1.45 | 96.7 | Palliative (P) | 2017-01-27 | 2017-02-17 | ECX | 2 | N | ECX | 100527494 |
| 20159242 | 20061113 | 1.81 | 65.75 | Palliative (P) | 2017-05-30 | 2017-06-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100182675 |
| 20159244 | 20061114 | 1.65 | 63 | Neo-adjuvant (N) | 2018-02-01 | 2018-02-15 | ECX | N | N | ECX | 100640522 |
| 20159245 | 20061115 | 1.8 | 75.6 | Palliative (P) | 2019-05-28 | 2019-05-31 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100684292 |
| 20159246 | 20061116 | 1.65 | 62.9 | Neo-adjuvant (N) | 2018-06-07 | 2018-06-22 | ECX | N | null | ECX | 101253058 |
| 20159247 | 20061117 | 1.6 | 62.6 | Palliative (P) | 2018-05-20 | 2018-05-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101254297 |
| 20159249 | 20061118 | 1.82 | 65.2 | Palliative (P) | 2016-06-01 | 2016-06-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101011071 |
| 20159250 | 20061119 | 1.68 | 87.1 | Neo-adjuvant (N) | 2018-03-30 | 2018-04-24 | ECX | 2 | N | ECX | 101153838 |
| 20159253 | 20061120 | 1.51 | 53.6 | Palliative (P) | 2019-02-05 | 2019-02-19 | ECX | N | N | ECX | 101470178 |
| 20159255 | 20061121 | 1.72 | 73.6 | Neo-adjuvant (N) | 2018-05-20 | 2018-05-25 | ECX | N | N | ECX | 101016641 |
| 20159258 | 20061122 | 1.83 | 63.6 | Adjuvant (A) | 2017-02-15 | 2017-02-17 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101512776 |
| 20159261 | 20061123 | null | 79 | Adjuvant (A) | 2017-03-31 | 2017-04-02 | ECX | 02 | N | ECX | 101054942 |
| 20159263 | 20061124 | 1.56 | 49.4 | Neo-adjuvant (N) | 2019-04-06 | 2019-04-06 | ECX | N | null | ECX | 100375438 |
| 20159267 | 20061125 | 1.6 | 58.9 | null | 2016-03-11 | 2016-03-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100572171 |
| 20159268 | 20061126 | 1.78 | 78.85 | null | 2017-10-11 | 2017-10-16 | ECX | N | N | ECX | 101201764 |
| 20159269 | 20061127 | 1.63 | 78.7 | Palliative (P) | 2016-12-16 | 2016-12-30 | ECX | null | null | CAPECITABINE + GEMCITABINE | 101437976 |
| 20159270 | 20061128 | 1.69 | 72 | Adjuvant (A) | 2017-05-09 | 2017-05-09 | ECX | 02 | N | ECX | 100945293 |